Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs RUCAPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs RUCAPARIB: Safety Overview

Metric ROZANOLIXIZUMAB RUCAPARIB
Total FAERS Reports 303 434
Deaths Reported 9 50
Death Rate 3.0% 11.5%
Hospitalizations 114 310
Average Patient Age 61.3 yrs 64.3 yrs
% Female Patients 60.9% 69.5%
Manufacturer UCB, Inc. N/A
Route SUBCUTANEOUS N/A